Rita K. Schmutzler

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D”.

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa030

N/A

0DataRank · unranked

166 citations

Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber +56 more

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134

N/A

0DataRank · unranked

67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00185-6

N/A

0DataRank · unranked

10 citations

Sofia Khan, Rainer Fagerholm, Kristiina Aittomäki, Julie M. Cunningham, Joe Dennis +39 more

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

UNC Libraries(2020)10.17615/dy70-ej71

N/A

0DataRank · unranked

0 citations

Kay‐Tee Khaw, Mark E. Robson, Diether Lambrechts, Janna Lilyquist, Emily Hallberg +95 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of Clinical Oncology(2022)10.1200/jco.21.02112

N/A

0DataRank · unranked

282 citations

Valentina Silvestri, Goska Leslie, Timothy R. Rebbeck, Susan L. Neuhausen, John L. Hopper +95 more

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

JAMA Oncology(2022)10.1001/jamaoncol.2021.6744

N/A

0DataRank · unranked

194 citations

Leila Dorling, Sara Carvalho, Jamie Allen, Anna González‐Neira, Renske Keeman +89 more

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

European Journal of Human Genetics(2022)10.1038/s41431-021-00987-7

N/A

0DataRank · unranked

73 citations

Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben +90 more

Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model

medRxiv(2022)10.1101/2022.07.08.22276452

N/A

0DataRank · unranked

3 citations

Lorenzo Ficorella, T.L.W. Carver, Anna Lee, AP Cunningham, Michael Lush +20 more

Exome sequencing identifies novel susceptibility genes and defines the contribution of coding variants to breast cancer risk

medRxiv(2022)10.1101/2022.06.17.22276537

N/A

0DataRank · unranked

1 citations

Martine Dumont, Anna González‐Neira, Sara Carvalho, Charles Joly Beauparlant, Marco Crotti +49 more

Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

Genetics in Medicine(2023)10.1016/j.gim.2023.100870

N/A

0DataRank · unranked

83 citations

Esteban Astiazarán-Symonds, Laura M. Amendola, Judith Balmañà, William D. Foulkes, Paul A. James +9 more

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

Nature Genetics(2023)10.1038/s41588-023-01466-z

N/A

0DataRank · unranked

63 citations

Martine Dumont, Anna González‐Neira, Sara Carvalho, Charles Joly Beauparlant, Marco Crotti +60 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Cancers(2023)10.3390/cancers15133313

N/A

0DataRank · unranked

1 citations

Amandine Billaud, Qin Wang, Manjeet K. Bolla, Joe Dennis, Michael Lush +76 more

Genetic drivers and cellular selection of female mosaic X chromosome loss

Nature(2024)10.1038/s41586-024-07533-7

N/A

0DataRank · unranked

45 citations

Giulio Genovese, Yajie Zhao, Matti Pirinen, Seyedeh M. Zekavat, Katherine A. Kentistou +95 more

Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae306

N/A

0DataRank · unranked

7 citations

Laura Madanat‐Harjuoja, Goska Leslie, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +68 more

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

The Breast(2025)10.1016/j.breast.2025.104619

N/A

0DataRank · unranked

1 citations

Gisella Figlioli, Clémence Mooser, Irene Casamassima, Violette Azzoni, Jahnavi Srivatsa +95 more